Foot & Mouth Disease Vaccine Market Size Worth $3.0 Billion By 2025: Grand View Research, Inc.

Wednesday, October 25, 2017 Research News
Email Print This Page Comment bookmark
Font : A-A+

SAN FRANCISCO, October 25, 2017 /PRNewswire/ --

The global foot and mouth disease (FMD) vaccine market is

expected to reach USD 3.0 billion by 2025, according to a new report by Grand View Research, Inc. Increase in incidence of FMD and their socioeconomic impact over international trade of animal products are propelling the
demand for FMD vaccines. In addition, effectiveness for lower time period propels repeat purchase of vaccines.

     (Logo: )

This market is highly competitive and various government entities intervene for bulk purchase of vaccines. There has been a dynamic growth in the global livestock population over the past few decades. In developing countries, the demand for livestock products is increasing owing to which concern for healthy livestock population is increasing. Rising demand for animal products has revolutionized the global livestock production. In addition, factors such as change in food preferences owing to changing lifestyle coupled with growing population are anticipated to boost the demand for livestock products.

Increased adoption of oil-based vaccines owing to their higher efficacy is expected to contribute to the largest share of conventional vaccines. Available conventional vaccines are effective in the prevention of clinical diseases; however, they offer protection for a shorter duration. Hence, as a prophylactic measure, frequent vaccination becomes necessary.

Browse full research report with TOC on "Foot and Mouth Disease (FMD) Vaccine Market Analysis By Technique (Conventional and Emergency Vaccines), By Animal Type (Cattle, Sheep & Goat, Pigs, Others), And Segment Forecasts, 2016 - 2025" at:

Further Key Findings From the Report Suggest: 

  • Conventional vaccines emerged as the largest segment because of increasing approvals of vaccines and higher efficacy
  • The cattle segment accounted for the largest share in the animal type segment owing to increase in domestic livestock population and number of outbreaks
  • Sheep and Goat segment is expected to grow at the fastest rate over the forecast period owing to rising incidence of FMD infection in sheep population and the need for reducing slaughter of infected animals.
  • Asia Pacific dominated the market with the largest share in 2016. Rise in incidence of FMD and increase in demand for livestock products are facilitating dominance of the region during the forecast period.
  • Key players including Agrovet Co.; Biogénesis Bago; Empresa Colombiana de Productos Veterinarios S.A. Vecol S.A.; FGBI - Federal Centre for Animal Health ; Indian Immunologicals Limited ; Merial (France); Veterinary Serum and Vaccine Research Institute; FMD Center; and Limor de Colombia are leading the global FMD vaccine market.

Browse related reports by Grand View Research: 

  • Gene Amplification Technologies Market -
  • Pediatric Vaccine Market -
  • Body Contouring Devices Market -
  • Pharmaceutical Logistics Market -

Grand View Research has segmented the global foot and mouth disease vaccine market based on technique, animal type, and region: 

  • Technique Outlook (Revenue, USD Million, 2014 - 2025)
    • Conventional vaccines
      • Aluminum hydroxide/Saponin-based vaccines
      • Oil-based vaccines
    • Emergency vaccines
  • Animal Type Outlook (Revenue, USD Million, 2014 - 2025)
    • Cattle
    • Sheep and Goat
    • Pigs
    • Others (antelope, deer, bison, camelids)
  • Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
    • Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • Malaysia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
    • Middle East & Africa
      • South Africa
      • Nigeria
      • Saudi Arabia

Read Our Blog By Grand View Research:

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: +1-415-349-0058 Toll Free: 1-888-202-9519 Email:


SOURCE Grand View Research, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store